Genetic Testing for Pheochromocytoma
- 12 October 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hypertension Reports
- Vol. 12 (6), 456-464
- https://doi.org/10.1007/s11906-010-0151-1
Abstract
Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are rare, catecholamine-producing tumors that are usually sporadic. However, about 30% of these tumors have been identified as being of inherited origin. To date, nine genes have been confirmed as participating in PHEO or PGL tumorigenesis. Germline mutations were found in 100% of syndromic cases and in about 90% of patients with positive familial history. In nonsyndromic patients with apparently sporadic tumors, genetic mutations have been found in up to 27%, and genetic testing is now recommended for all patients with PHEOs and PGLs. Patients with syndromic lesions, a positive family history, or both should be tested for the appertaining gene. Recent discoveries have shown that the order of tested genes in nonsyndromic, nonfamilial cases can be based on histologic evaluation, location, and the biochemical phenotype of PHEOs and PGLs—the “rule of three.” Identification of a gene mutation may lead to early diagnosis and treatment, regular surveillance, and a better prognosis for patients and their relatives.Keywords
This publication has 51 references indexed in Scilit:
- SDHA is a tumor suppressor gene causing paragangliomaHuman Molecular Genetics, 2010
- Germline mutations in TMEM127 confer susceptibility to pheochromocytomaNature Genetics, 2010
- Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma PatientsClinical Cancer Research, 2009
- SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in ParagangliomaScience, 2009
- Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2Journal of Clinical Endocrinology & Metabolism, 2009
- Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumoursEndocrine-Related Cancer, 2009
- Clinical aspects of SDHx-related pheochromocytoma and paragangliomaEndocrine-Related Cancer, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Pheochromocytoma: recommendations for clinical practice from the First International SymposiumNature Clinical Practice Endocrinology & Metabolism, 2007
- Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma SyndromesJournal of Clinical Endocrinology & Metabolism, 2006